Colin D. Weekes, M.D., PhD
2 clinical trials · Sponsor
◉ Watch Colin D. Weekes, M.D., PhD
| Record | Firm | Date |
|---|---|---|
| FOLFIRINOX + NIS793 in Pancreatic Cancer (NCT05417386) | Colin D. Weekes, M.D., PhD | 2022-08-09 |
| FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer (NCT05077800) | Colin D. Weekes, M.D., PhD | 2022-03-21 |
Track Colin D. Weekes, M.D., PhD automatically
Every clearance here is in the API, with alerts when new ones post.